| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |